Pharmafile Logo

Claire Long

- PMLiVE

Paolo Carli appointed as head of MEA at Merck

He will be responsible for leading commercial operations

Perspective on biotech

In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating.

Blue Latitude Health

- PMLiVE

Lucid CEO discusses communication excellence in a multimedia world

“The two words 'information' and 'communication' are often used interchangeably, but they signify quite different things. Information is giving out; communication is getting through,” Sydney J. Harris, a renowned Anglo-American...

Lucid Group Communications Limited

- PMLiVE

Can big data give medical affairs an edge in strategic planning?

Teams can better identify, and engage with, KOLs while also measuring their endeavours

What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach

Wilmington Healthcare

Roche Basel Switzerland

Roche’s Actemra/RoActemra receives new European approval

EU regulators also pass the Swiss pharma firm’s Gazyvaro

- PMLiVE

Versartis crashes as VELOCITY trial veers off track

The US biotech's somavaratan proved inferior to Pfzier’s Genotropin

- PMLiVE

FDA wants more data on J&J’s arthritis drug Plivensia

Requests further evidence on the drug’s safety profile after patient deaths link

- PMLiVE

Prof Sir Mike Richards joins Incisive Health as senior counsel

He recently stepped down as chief inspector of hospitals

AI’s potential in the pharma life cycle

At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...

- PMLiVE

Dr Paula Salmikangas joins NDA Group

Moves to the regulatory affairs consultancy from the Finnish Medicines Agency

- PMLiVE

And breathe…

…or, why there is no ‘fast track’  to communications excellence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links